ST Louis-Cape Girardeau CCOP

描述（由申请人提供）：圣路易斯-开普吉拉多CCOP是一个由五家医院组成的财团，服务于密苏里州东部和伊利诺伊州西部的部分地区。该组织的使命是为社区肿瘤学家及其患者提供临床试验的途径。圣约翰慈悲医疗中心是圣路易斯县的一家三级医疗教学医院，是CCOP的主要机构。其他组成部分医院主要位于病人人数不足的较小的农村社区。为这些患者在他们自己的社区提供最先进的癌症治疗，从而增加这些人群对临床研究的参与，是CCOP的重要目标。所有累积到NCI治疗和预防试验的患者中有三分之一是在CCOP站点注册的。该项目包括癌症治疗、预防和控制研究，不仅有利于癌症患者，也有利于癌症高危人群。它提供多种II期和III期方案，包括通过RTOG进行放射治疗，通过NSABP对乳腺癌和结直肠癌进行辅助治疗，以及通过SWOG对所有主要癌症类型进行基于化疗的治疗。根据需要使用CTSU菜单来补充临床试验的曲目。在接下来的五年里，每年大约有80名患者将通过圣路易斯-开普吉拉多CCOP参加癌症治疗试验。SWOG， NSABP和RTOG也提供癌症预防和控制研究，这是CCOP的主要重点。St. Louis-Cape Girardeau CCOP是STAR乳腺癌预防研究的顶级积累点之一，并期待即将到来的STELLAR研究取得类似的成功。在这一赠款期间，预计每年约有60个癌症预防和控制信贷。通过提供癌症治疗和预防的临床试验，CCOP希望改善伊利诺伊州西部和密苏里州东部社区的癌症护理。当临床试验参与者来自社区医院而不仅仅是大学时，研究结果更适用于一般人群。圣路易斯-开普吉拉多社区临床肿瘤项目将尽其所能实现NCI消除癌症带来的痛苦和死亡的目标。

DESCRIPTION (provided by applicant): The St. Louis-Cape Girardeau CCOP is a consortium of five hospitals serving parts of eastern Missouri and western Illinois. The mission of this organization is to provide access to clinical trials for community oncologists and their patients. St. John's Mercy Medical Center, the primary institution in the CCOP, is a tertiary care teaching hospital in St. Louis County. The other component hospitals are primarily located is smaller, rural communities with underserved patient populations. Providing access to state-of-the-art cancer treatment to these patients in their own community, and thus increasing involvement of these populations in clinical research, are important goals of the CCOP. One-thrid of all patients accrued to NCI treatment and preventiontrials are enrolled at CCOP sites. The program includes cancer treatment, prevention and control studies that benefit not only people with cancer but also people at high risk for cancer. It offers a variety of Phase II and III protocols including radiation therapy through RTOG, adjuvant treatment of breast and colorectal cancer through NSABP, and chemotherapy-based treatment of all major cancer types through SWOG. The repertoire of clinical trials is supplemented by using the CTSU menu as needed. Over the next five years approximately 80 patients per year will be enrolled in cancer treatment trials through the St. Louis-Cape Girardeau CCOP. SWOG, NSABP, and RTOG also offer cancer prevention and control studies which are a major focus of the CCOP. The St. Louis-Cape Girardeau CCOP was one of the top accruing sites for the STAR breast cancer prevention study and anticipates similar success with the upcoming STELLAR study. Approximately 60 cancer prevention and control credits are expected during each year of this grant period. By providing access to clinical trials in cancer treatment and prevention, the CCOP hopes to improve cancer care in the communities of western Illinois and eastern Missouri. When clinical trial participants are drawn from community hospitals and not just from universities, the study results are more applicable and relevant to the general population. The St. Louis-Cape Girardeau Community Clinical Oncology Program will do its part to achieve the NCI's goal to eliminate suffering and death due to cancer.